Ep78: Pearl Huang on Exoneural Cancer Biology

The Long Run with Luke Timmerman - A podcast by Timmerman Report

Podcast artwork

Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology

Visit the podcast's native language site